Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Joseph Beechem, Hugh Martin

Premium

Joseph Beechem has left his position as head of advanced sequencing and global sequencing chemistry, biochemistry, and biophysics at Life Technologies to join NanoString as senior vice president of research and development.

While at Life Tech, he led the design and development of multiple sequencing technologies for the SOLiD platform, including an emulsion PCR-free sample-prep technology called WildFire that Life Tech plans to launch this year. He holds a BS in chemistry and biology from Northern Kentucky University and a PhD in biophysics from Johns Hopkins University.

Beechem has also served as chief technology officer at Life Tech, chief scientific officer of Invitrogen, and director of biosciences at Molecular Probes.


Hugh Martin has resigned from Pacific Biosciences' board of directors for personal reasons, effective immediately. Martin was previously the firm's president and CEO but resigned at the beginning of the year and was replaced by Michael Hunkapiller (IS 1/10/2012). He had led the company since 2004 and has been battling multiple myeloma, with which he was diagnosed in 2009.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.